Inducible expression of Mad accelerates growth arrest of serum deprived human glioblastoma cells
暂无分享,去创建一个
[1] D. Reisman,et al. Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors , 1994, Molecular and cellular biology.
[2] S Gaubatz,et al. An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc , 1994, Molecular and cellular biology.
[3] R. Eisenman,et al. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. , 1993, Genes & development.
[4] J L Cleveland,et al. The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] W. Gu,et al. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] V. Rotter,et al. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[7] R. Eisenman,et al. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.
[8] Bruno Amati,et al. Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.
[9] N. Hay,et al. Sequence-specific transcriptional activation by Myc and repression by Max , 1993, Molecular and cellular biology.
[10] G. Prendergast,et al. Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. , 1992, Genes & development.
[11] R. Eisenman,et al. Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.
[12] G. Evan,et al. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max , 1992, Nature.
[13] R. DePinho,et al. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. , 1992, Genes & development.
[14] B. Wold,et al. c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation , 1991, Molecular and cellular biology.
[15] J. Bishop,et al. The MYC protein activates transcription of the alpha‐prothymosin gene. , 1991, The EMBO journal.
[16] E. Appella,et al. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[18] M. Cole,et al. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment , 1986, Nature.
[19] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.
[20] R. Eisenman,et al. Myc and Max associate in vivo. , 1992, Genes & development.
[21] R. Eisenman,et al. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. , 1991, Science.
[22] M. Cole. The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.